The isCGM Use and Hypoglycemic Episodes and Fear of Hypoglycemia in Newly Diagnosed Type 1 Diabetes

Inclusion Criteria: * Newly diagnosed type 1 diabetes (diagnosed based on the WHO criteria) no later than 6 months after the diagnosis. * Insulin therapy: multiple daily injections, * In the investigator's opinion, the participant must be technically capable of using the FreeStyle Libre system Exclusion Criteria: * Current or past use of any continuous glucose monitoring system. * Pump therapy. * Known allergy to medical adhesives. * Oral steroid therapy. * Pregnancy or planning pregnancy within the study duration. * Breast feeding. * Dialysis treatment. * Having a pacemaker. * Unstable coronary heart disease. * Cystic fibrosis. * Cancer. * Psychiatric disorders. * Severe end-organ damage (kidney, liver, etc) or any uncontrolled disorder. * Hospitalization for any reason other than the newly diagnosed type 1 diabetes 6 months prior to inclusion. * Participating in another clinical trial that could affect glucose measurements or glucose management. * In the investigator's opinion, if the participant is considered unsuitable for inclusion in the study for any other reason.